FFCP PHASE2:Hg19::chr5:126305543..126305566,+
From FANTOM5_SSTAR
Revision as of 09:19, 30 July 2015 by Autoedit (talk | contribs) (Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene=NA |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript |HGNC=NA |TSSclassifier=stron...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p@chr5:126305543..126305566, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr5:126305543..126305566, + |
Coexpression cluster: | C183_acute_non_CD34_diffuse_CD133_myeloma_Burkitt |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p@chr5:126305543..126305566+ |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 1.29e-34 | 24 |
pro-B cell | 1.29e-34 | 24 |
lymphoid lineage restricted progenitor cell | 2.60e-16 | 52 |
lymphocyte | 5.16e-16 | 53 |
common lymphoid progenitor | 5.16e-16 | 53 |
precursor B cell | 1.85e-12 | 3 |
B cell | 1.90e-10 | 14 |
nongranular leukocyte | 1.50e-07 | 115 |
hematopoietic lineage restricted progenitor cell | 2.99e-07 | 120 |
Showing 1 to 9 of 9 entries
Ontology term | p-value | n |
---|---|---|
anemia | 5.05e-34 | 1 |
lymphoma | 2.78e-30 | 10 |
hematopoietic system disease | 9.07e-18 | 2 |
hematologic cancer | 5.89e-11 | 51 |
immune system cancer | 5.89e-11 | 51 |
cardiovascular system disease | 1.44e-09 | 4 |
Showing 1 to 6 of 6 entries